The blood thinner Pradaxa is prescribed to prevent blood clots and stroke in patients with atrial fibrillation or who have undergone surgery. Unfortunately, repeated warnings have now associated it with severe internal bleeding.
The FDA approved Pradaxa in 2010, and within six months, patients were reporting serious bleeding events. Although the agency has received over 4,000 reports of side effects and 542 deaths among users, they have not issued a recall. The maker of the drug, Boehringer Ingelheim, also failed to warn of these potential dangers and the fact that no antidote existed to stop them. If you or a loved one suffered injuries after the use of pradaxa during a surgery, call The Goss Law Firm, P.C. for a free consultation.